Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May 28;135(22):1927-1928.
doi: 10.1182/blood.2020005714.

Shaping clonal hematopoiesis

Affiliations
Comment

Shaping clonal hematopoiesis

Daniel C Link. Blood. .

Abstract

In this issue of Blood, Eskelund et al characterize clonal hematopoiesis in serial samples from persons with mantle cell lymphoma (MCL) undergoing frontline treatment, providing evidence that treatment plays an important role in the development of clonal hematopoiesis.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The author declares no competing financial interests.

Conflict-of-interest disclosure: The author declares no competing financial interests.

Figures

None
Evolution of clonal hematopoiesis during treatment of persons with MCL. HSPCs acquire somatic mutations with aging, resulting in the production of a genetically heterogenous pool of HPSCs. Genotoxic stress induced by chemotherapy favors the selection of HSP-Cs carrying mutations of DNA damage response genes, such as TP53 and PPM1D (red cells). Auto-HCT induces replicative stress and potentially other stresses related to an altered bone marrow microenvironment. In this study, auto-HCT was associated with the selective expansion of HPSCs carrying DNTM3A R882 mutations (purple cells). During long-term follow-up, the existing clonal hematopoiesis was mostly stable.

Comment on

References

    1. Eskelund CW, Husby S, Favero F, et al. . Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL. Blood. 2020;135(22):2000-2004. - PubMed
    1. Wong TN, Miller CA, Jotte MRM, et al. . Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential. Nat Commun. 2018;9(1):455-468. - PMC - PubMed
    1. Coombs CC, Zehir A, Devlin SM, et al. . Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell. 2017;21(3):374-382.e4. - PMC - PubMed
    1. Wong TN, Miller CA, Klco JM, et al. . Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML. Blood. 2016;127(7):893-897. - PMC - PubMed
    1. Cai Z, Kotzin JJ, Ramdas B, et al. . Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis. Cell Stem Cell. 2018;23(6):833-849.e5. - PMC - PubMed